Log In
BCIQ
Print this Print this
 

Ronacaleret (751689) (formerly SB-751689)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionSmall molecule calcium sensing receptor (CaSR) antagonist
Molecular Target Calcium sensing receptor (CaSR)
Mechanism of ActionCalcium-sensing receptor (CaSR) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Transplant (unspecified)
Indication DetailsHematopoetic stem cell transplant (HSCT)
Regulatory Designation
PartnerGlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$5,200.0M

$2,250.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/21/2015

$5,200.0M

$2,250.0M

0

Get a free BioCentury trial today